Efficacy of elental on prevention for chemotherapy-induced oral mucositis in colorectal cancer patients

Japanese Journal of Cancer and Chemotherapy

Volumn 39, Issue 4, 2012, Pages 583-587

  Ogata, Yutaka ^a   Takeuchi, Masaaki ^a   Ishibashi, Nobuya ^a   Kibe, Shirou ^a   Takahashi, Kenjirou ^a   Uchida, Shinji ^a   Murakami, Naotaka ^a   Yahara, Toshirou ^a   Shirouzu, Kazuo ^b  

^a KURUME UNIVERSITY MEDICAL CENTER   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Colorectal cancer; Elemental diet elental; Oral mucositis

Indexed keywords

CAPECITABINE PLUS OXALIPLATIN; FLUOROURACIL; FOLINIC ACID; GLUTAMINE; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG EFFICACY; ELEMENTAL DIET; HUMAN; NEUTROPENIA; ORAL MUCOSITIS;

EID: 84862553591     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355(9209): 1041-1047, 2000.
2. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16): 2938-2947, 2000
3. Noé JE: L-glutamine use in the treatment and prevention of mucositis and cachexia: a naturopathic perspective. Integr Cancer Ther 8(4): 409-415, 2009.
4. Redding SW: Cancer therapy-related oral mucositis. J Dent Educ 69(8): 919-929, 2005.
5. Keefe DM, Schubert MM, Elting LS, et al: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109(5): 820-831, 2007.
6. Choi K, Lee SS, Oh SJ, et al: The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr 26(1): 57-62, 2007.
7. Goto A, Yamada Y, Yasui H, et al: Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer. Ann Oncol 17(6): 968-973, 2006.
8. Vermeulen MA, van de Poll MC, Ligthart-Melis GC, et al: Specific amino acids in the critically ill patient-Exogenous glutamine/arginine: A common denominator ? Crit Care Med 35(9 Suppl): S568-576, 2007.
9. Skubitz KM and Anderson PM: Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med 127(2): 223-228, 1996.
10. Spielberger R, Stiff P, Bensinger W, et al: Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351(25): 2590-2598, 2004.
11. Peterson DE, Jones JB and Petit RG 2nd: Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer 109(2): 322-331, 2007.